We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Cytokine Assay for Early Identification of Pediatric Stem Cell Transplant Recipients

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified June 2010 by Stanford University.
Recruitment status was:  Recruiting
Sponsor:
ClinicalTrials.gov Identifier:
NCT01135355
First Posted: June 2, 2010
Last Update Posted: June 17, 2010
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Stanford University
June 1, 2010
June 2, 2010
June 17, 2010
July 2008
December 2010   (Final data collection date for primary outcome measure)
Not Provided
Not Provided
Complete list of historical versions of study NCT01135355 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Cytokine Assay for Early Identification of Pediatric Stem Cell Transplant Recipients
Cytokine Assay for Early Identification of Pediatric Stem Cell Transplant Recipients at Risk for Respiratory Failure
The aim of our study is to determine whether a clinically relevant laboratory measurement (of seven specific immunologic biochemicals in the blood) can identify which bone marrow transplant recipients are likely to progress to respiratory failure. Our ultimate goal is to devise a comprehensive and inclusive laboratory test that is effective at determining who is likely to go on to respiratory failure, in order to facilitate early medical intervention.
Not Provided
Observational
Observational Model: Cohort
Time Perspective: Prospective
Not Provided
Retention:   Samples With DNA
Description:
blood
Non-Probability Sample
Hematopoietic stem cell transplantation (HSCT) for any indication.
  • Stem Cell Transplantation
  • Blood and Marrow Transplant (BMT)
Not Provided
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Unknown status
50
July 2011
December 2010   (Final data collection date for primary outcome measure)

Inclusion Criteria:- Hematopoietic stem cell transplantation (HSCT) for any indication.

  • Patients will range from age 0 to age 21. There is no gender restriction. We expect the male to female ratio to end up being about 50/50
  • Ability to understand and the willingness to sign a written informed consent document.
Sexes Eligible for Study: All
up to 21 Years   (Child, Adult)
No
Contact information is only displayed when the study is recruiting subjects
United States
 
 
NCT01135355
SU-09222008-1301
PEDSBMT199
PEDSHSCT0002
Not Provided
Not Provided
Not Provided
Rajni Agarwal-Hashmi, Stanford University School of Medicine
Stanford University
Not Provided
Principal Investigator: Rajni Agarwal-Hashmi Stanford University
Stanford University
June 2010